Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes
Faricimab demonstrates early and significant efficacy in improving PED architecture in patients with nAMD. The rapid morphological improvements observed in this study suggest faricimab may represent a valid therapeutic option for PEDs associated with nAMD.
Authors
- Daniele Veritti (ORCID: https://orcid.org/0000-0003-0148-5348)
- Paolo Lanzetta (ORCID: https://orcid.org/0000-0003-3746-141X)
- Valentina Sarao (ORCID: https://orcid.org/0000-0003-0041-5073)
- Leopoldo Rubinato (ORCID: https://orcid.org/0009-0003-0607-6516)
- Marco Gonfiantini (ORCID: https://orcid.org/0009-0009-1580-7118)
Institutions
- University of Udine (IT)
- Istituto Europeo di Microchirurgia Oculare (IT)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1007/s40123-024-01005-x
- Citations
- 16
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.62